Diabetes Tools Sweden AB, maker of the TriabetesClinic online service that puts apps at the heart of diabetes care plans, today agreed to acquire the DiabetesGuru smartphone app for children from Shore Innovation AB. This agreement transfers the rights to Diabetes Tools while still allowing the developer behind DiabetesGuru, Henrik Sjöstrand, to support the project with advice.
"The deal with DiabetesGuru adds a new dimension to our digital health product portfolio," said Diabetes Tools' Chief Executive Officer Anders Weilandt. "Whereas TriabetesGo, our app for keeping insulin-dependent children connected with their families and doctors, is exclusively available from treatment clinics using the TriabetesClinic service, DiabetesGuru is a standalone app and can therefore be used by children and families when a TriabetesClinic affiliation is not offered in their local area."
"I created DiabetesGuru out of necessity to help my young son with his diabetes," said DiabetesGuru's developer and Shore Innovation's CEO Henrik Sjöstrand. "Now the app helps hundreds of insulin-dependent children across Sweden. Since I do this in my spare time, now is the right time to move the app to a more professional setting. I am delighted that Diabetes Tools has agreed to take it over. It's a move that will allow many more families to benefit from the hard work I have put into it."
According to today's deal, Diabetes Tools will own the rights to the DiabetesGuru app in addition to other marketing and brand assets. The software assets will be formally transferred during the next few months so DiabetesGuru can become part of the Diabetes Tools quality management framework and product portfolio. Then, the company expects to offer DiabetesGuru as a free-of-charge, standalone app available from online app stores as it is today.
About Diabetes Tools
Diabetes Tools is a Swedish medical technology company that simplifies daily life for everyone involved in diabetes care. The TriabetesClinic software service securely combines apps (for smartphones and tablets), online accounts and web interfaces to change diabetes healthcare for the better.
Diabetes Tools was named “MedTech Company of the Year 2014” by the Swedish Medtech Association. The company holds an ISO 13485 certificate, a compliance standard for creating medical devices and related services, and sells CE-marked medical software products in the European Union. Diabetes Tools is privately held and located in Stockholm, Sweden. For more information, visit http://www.diabetestools.se.